Literature DB >> 10195285

A three-dimensional construction of the active site (region 507-749) of human neutral endopeptidase (EC.3.4.24.11).

G Tiraboschi1, N Jullian, V Thery, S Antonczak, M C Fournie-Zaluski, B P Roques.   

Abstract

A three-dimensional model of the 507-749 region of neutral endopeptidase-24.11 (NEP; E.C.3.4.24.11) was constructed integrating the results of secondary structure predictions and sequence homologies with the bacterial endopeptidase thermolysin. Additional data were extracted from the structure of two other metalloproteases, astacin and stromelysin. The resulting model accounts for the main biological properties of NEP and has been used to describe the environment close to the zinc atom defining the catalytic site. The analysis of several thiol inhibitors, complexed in the model active site, revealed the presence of a large hydrophobic pocket at the S1' subsite level. This is supported by the nature of the constitutive amino acids. The computed energies of bound inhibitors correspond with the relative affinities of the stereoisomers of benzofused macrocycle derivatives of thiorphan. The model could be used to facilitate the design of new NEP inhibitors, as illustrated in the paper.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10195285     DOI: 10.1093/protein/12.2.141

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  9 in total

1.  Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites.

Authors:  Nicolas Le Novère; Thomas Grutter; Jean-Pierre Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

Review 2.  Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Authors:  Bernard P Roques; Marie-Claude Fournié-Zaluski; Michel Wurm
Journal:  Nat Rev Drug Discov       Date:  2012-04       Impact factor: 84.694

3.  Quantitative analysis of the conservation of the tertiary structure of protein segments.

Authors:  Jishou Ruan; Ke Chen; Jack A Tuszynski; Lukasz A Kurgan
Journal:  Protein J       Date:  2006-07       Impact factor: 2.371

4.  An insight into the sequential, structural and phylogenetic properties of banana 1-aminocyclopropane-1-carboxylate synthase 1 and study of its interaction with pyridoxal-5'-phosphate and aminoethoxyvinylglycine.

Authors:  Swarup Roy Choudhury; Sanjay Kumar Singh; Sujit Roy; Dibyendu N Sengupta
Journal:  J Biosci       Date:  2010-06       Impact factor: 1.826

5.  Computer modeling and nanosecond simulation of the enzyme-substrate complex of the common lymphoblastic leukemia antigen (neprilysin) indicates shared residues at the primary specificity pocket (S1') with matrix metalloproteases.

Authors:  Sergio Manzetti
Journal:  J Mol Model       Date:  2003-08-29       Impact factor: 1.810

6.  Homology modeling and site-directed mutagenesis to identify selective inhibitors of endothelin-converting enzyme-2.

Authors:  Khatuna Gagnidze; Raphael Rozenfeld; Mihaly Mezei; Ming-Ming Zhou; Lakshmi A Devi
Journal:  J Med Chem       Date:  2008-05-29       Impact factor: 7.446

7.  Stimulation and oxidative catalytic inactivation of thermolysin by copper.Cys-Gly-His-Lys.

Authors:  Nikhil H Gokhale; Seth Bradford; J A Cowan
Journal:  J Biol Inorg Chem       Date:  2007-07-06       Impact factor: 3.358

8.  Engineering neprilysin activity and specificity to create a novel therapeutic for Alzheimer's disease.

Authors:  Carl I Webster; Matthew Burrell; Lise-Lotte Olsson; Susan B Fowler; Sarah Digby; Alan Sandercock; Arjan Snijder; Jan Tebbe; Ulrich Haupts; Joanna Grudzinska; Lutz Jermutus; Christin Andersson
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

9.  Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin-Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme.

Authors:  Urvashi Sharma; Gyles E Cozier; Edward D Sturrock; K Ravi Acharya
Journal:  J Med Chem       Date:  2020-05-08       Impact factor: 7.446

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.